Litecoin Testing Resistance, 16 Percent Rally Toward $136 In Sight

[MadWhale]

Fundamental analysis:
MEI Pharma became Lite Strategy and put $100M in Litecoin (LTC).
EU rules now make LTC a regulated asset, easing big investors in and cutting sell pressure.

Technical analysis:

LTCUSDT
precisely hit my previous target and is now testing two key daily supports and a critical trendline.
It is also near the upper boundary of its parallel channel.
A breakout above this level could trigger a 16% rally toward $136.